Increasing Vaginal <i>Chlamydia Trachomatis</i> Testing in Adolescent and Young Adults.

Abstract

The Centers for Disease Control and Prevention recommend testing for <i>Chlamydia trachomatis</i> in sexually active female patients <25 years old using nucleic-acid amplification tests (NAAT) from a vaginal swab. Our providers were typically testing using the less sensitive urine NAATs. We aimed to increase the percentage of urogenital <i>C trachomatis</i> NAATs performed by using vaginal swabs in adolescent female patients ages 10 through 20 years from 1.4% to 25%. We implemented 3 interventions at 3 pediatric practices over 12 months including education, process standardization, and cross-training. We used statistical process control to analyze the effect of interventions on our primary outcome: the percentage of urogenital <i>C trachomatis</i> tests performed with a vaginal swab. Our balance measure was the total number of urogenital <i>C trachomatis</i> tests. There were 818 urogenital <i>C trachomatis</i> tests performed: 289 before and 529 after the first intervention. Of urogenital <i>C trachomatis</i> tests in the preintervention time period, 1.4% were performed by using vaginal swabs. We surpassed our aim of 25% 6 weeks after the first intervention. We noted sustained improvement after the second intervention, with an average of 68.3% of tests performed by using vaginal swabs for the remaining postintervention period. There was no difference in the overall number of urogenital <i>C trachomatis</i> tests pre- and postintervention. Using quality improvement methodology and implementing easily replicable interventions, we significantly and sustainably increased use of vaginal swabs. The interventions standardizing processes were associated with a higher impact than the educational intervention.